ExodusPoint Capital Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

ExodusPoint Capital Management’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-20,000	Closed	-$349K	–	2838
2020 Q4	$349K	Sell	20,000 -14,291	-42%	-$200K	﹤0.01%	1458
2020 Q3	$401K	Buy	+34,291	New	+$455K	0.01%	1138
2019 Q4	–	Sell	-13,539	Closed	-$225K	–	2030
2019 Q3	$225K	Sell	13,539 -9,123	-40%	-$126K	0.01%	1060
2019 Q2	$312K	Buy	+22,662	New	+$347K	0.01%	674

ExodusPoint Capital Management's OXFD Position: Q1 2021 in Review

ExodusPoint Capital Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 20,000 shares — an estimated $349K sold.

ExodusPoint Capital Management first reported a position in OXFD in Q2 2019 and held it in 4 quarters. The position peaked at $401K in Q3 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

ExodusPoint Capital Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
ExodusPoint Capital Management sold 20,000 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $349K.
ExodusPoint Capital Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2019 and held it in 4 quarters.
ExodusPoint Capital Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $401K in Q3 2020.
0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on ExodusPoint Capital Management's 13F filing for Q1 2021, filed 17 May 2021.